Skip to contentSkip to navigation

s+b Trend Watch: Big Pharma’s Potential in Emerging Markets

Emerging economies are becoming the industry's best hope for growth.

(originally published by Booz & Company)

Pharmaceutical markets in developed countries may still be quite sizable, but in 2011–12 they were mostly stagnant—or worse. Not so in emerging economies, which are becoming the industry’s best hope for growth.


Get s+b's award-winning newsletter delivered to your inbox. Sign up No, thanks
Illustration of flying birds delivering information
Get the newsletter

Sign up now to get our top insights on business strategy and management trends, delivered straight to your inbox twice a week.